Overview

Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

The primary purpose of this study is to evaluate the safety and tolerability of multiple oral doses of BMS-779788 in healthy subjects

Phase:

Phase 1

Details

Lead Sponsor:

Bristol-Myers Squibb